Carl Zeiss Meditec AG (LON:0DHC)

Market Cap	4.41B
Revenue (ttm)	1.72B
Net Income (ttm)	129.86M
Shares Out	n/a
EPS (ttm)	1.47
PE Ratio	33.92
Forward PE	n/a
Dividend	0.50 (0.84%)
Ex-Dividend Date	Mar 27, 2025

Volume	1,098
Average Volume	21,921
Open	56.50
Previous Close	n/a
Day's Range	56.10 - 59.25
52-Week Range	37.27 - 102.13
Beta	1.23
RSI	51.60
Earnings Date	May 14, 2025

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1846
• Employees: 5,730
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0DHC

Financial Performance

In 2024, Carl Zeiss Meditec AG's revenue was 2.07 billion, a decrease of -1.11% compared to the previous year's 2.09 billion. Earnings were 178.73 million, a decrease of -38.45%.

Financial numbers in EUR